Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Farolfi

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
International Journal of Molecular Sciences|December 23, 2022
Clinical Impact of Next-Generation Sequencing Multi-Gene Panel Highlighting the Landscape of Germline Alterations in Ovarian Cancer PatientsGiorgia Gurioli, Gianluca Tedaldi, Alberto Farolfi, et al.
JAMA Network Open|July 14, 2026
Bevacizumab and Platinum Choice in Pembrolizumab-Treated Advanced Cervical CancerAlberto Farolfi, Chiara Casadei, Emanuela Scarpi, et al.
Scientific Reports|October 24, 2020
Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective studyAlberto Farolfi, Emanuela Scarpi, Filippo Greco, et al.
Targeted Oncology|June 28, 2018
Inflammatory Indexes as Prognostic and Predictive Factors in Ovarian Cancer Treated with Chemotherapy Alone or Together with Bevacizumab. A Multicenter, Retrospective Analysis by the MITO Group (MITO 24)Alberto Farolfi, Micaela Petrone, Emanuela Scarpi, et al.
The Oncologist|May 16, 2025
Changing metastatic patterns associate with dynamics of circulating tumor DNA in metastatic castration-resistant prostate cancerVincenza Conteduca, Emanuela Scarpi, Alice Rossi, et al.
Breast (Edinburgh, Scotland)|July 7, 2026
Artificial intelligence for predicting pathological complete response to neoadjuvant therapy in triple-negative breast cancer: A systematic review and meta-analysisAndrea Carlini, Flavia Foca, Marianna Sirico, et al.
European Urology Open Science|February 22, 2024
Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 StudyChiara Casadei, Emanuela Scarpi, Vincenza Conteduca, et al.
Critical Reviews in Oncology/Hematology|May 8, 2024
Unlocking the potential of Molecular Tumor Boards: from cutting-edge data interpretation to innovative clinical pathwaysBrenno Pastò, Giulia Buzzatti, Clorinda Schettino, et al.
Gynecologic Oncology|March 22, 2024
Alpelisib for PIK3CA-mutated advanced gynecological cancers: First clues of clinical activityAnna Passarelli, Vittoria Carbone, Sandro Pignata, et al.
Breast (Edinburgh, Scotland)|July 13, 2024
Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancerEleonora Pagan, Monica Ruggeri, Nadia Bianco, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
International Journal of Molecular Sciences|December 23, 2022
Clinical Impact of Next-Generation Sequencing Multi-Gene Panel Highlighting the Landscape of Germline Alterations in Ovarian Cancer PatientsGiorgia Gurioli, Gianluca Tedaldi, Alberto Farolfi, et al.
JAMA Network Open|July 14, 2026
Bevacizumab and Platinum Choice in Pembrolizumab-Treated Advanced Cervical CancerAlberto Farolfi, Chiara Casadei, Emanuela Scarpi, et al.
Scientific Reports|October 24, 2020
Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective studyAlberto Farolfi, Emanuela Scarpi, Filippo Greco, et al.
Targeted Oncology|June 28, 2018
Inflammatory Indexes as Prognostic and Predictive Factors in Ovarian Cancer Treated with Chemotherapy Alone or Together with Bevacizumab. A Multicenter, Retrospective Analysis by the MITO Group (MITO 24)Alberto Farolfi, Micaela Petrone, Emanuela Scarpi, et al.
The Oncologist|May 16, 2025
Changing metastatic patterns associate with dynamics of circulating tumor DNA in metastatic castration-resistant prostate cancerVincenza Conteduca, Emanuela Scarpi, Alice Rossi, et al.
Breast (Edinburgh, Scotland)|July 7, 2026
Artificial intelligence for predicting pathological complete response to neoadjuvant therapy in triple-negative breast cancer: A systematic review and meta-analysisAndrea Carlini, Flavia Foca, Marianna Sirico, et al.
European Urology Open Science|February 22, 2024
Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 StudyChiara Casadei, Emanuela Scarpi, Vincenza Conteduca, et al.
Critical Reviews in Oncology/Hematology|May 8, 2024
Unlocking the potential of Molecular Tumor Boards: from cutting-edge data interpretation to innovative clinical pathwaysBrenno Pastò, Giulia Buzzatti, Clorinda Schettino, et al.
Gynecologic Oncology|March 22, 2024
Alpelisib for PIK3CA-mutated advanced gynecological cancers: First clues of clinical activityAnna Passarelli, Vittoria Carbone, Sandro Pignata, et al.
Breast (Edinburgh, Scotland)|July 13, 2024
Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancerEleonora Pagan, Monica Ruggeri, Nadia Bianco, et al.
Pageof 7